| Sr.No |
Compositon |
|
| 1. |
Clotrimazole IP |
1%w/w |
| In a cream base |
q.s |
| |
|
|
| 2. |
Clotrimazole IP |
1% w/w |
| Beclomethasone Dipropionate IP |
0.025% w/w |
| In a cream base |
q.s |
| |
|
|
| 3. |
Fluticasone Propionate BP |
0.05%w/w |
| In a cream base |
q.s |
| |
|
|
| 4. |
Povidone Iodine IP |
5.0%w/w |
| (Available Iodine 0.5%w/w) |
|
| In a water soluble ointment baseIn a water soluble ointment base |
q.sq.s |
| |
|
|
| 5. |
Clotrimazole IP |
1% w/v |
| In Propylene Glycol IP |
|
| And Glycerine IP Base |
q.s |
| |
|
|
| 6. |
Clotrimazole gel IP |
2%w/w |
| In gel base |
q.s |
| |
|
|
| 7. |
Clobetasol Propionate BP |
0.05% w/w |
| In a cream base |
q.s |
| |
|
|
| 8. |
Clobetasol propionate BP |
0.05% w/w |
| Salicylic Acid IP |
3% w/w |
| In a ointment base. |
q.s |
| |
|
|
| 9. |
Clobetasol propionate BP |
0.05% w/w |
| Salicylic Acid IP |
6% w/w |
| In a ointment base. |
q.s |
| |
|
|
| 10. |
Fusidic Acid IP |
2%w/w |
| Beclomethasone Dipropionate IP |
0.025%w/w |
| In a cream Base |
q.s |
| |
|
|
| 11. |
Metronidazole IP |
1.0% w/w |
| Povidone Iodine IP |
5.0% w/w |
| (Available Iodine 0.5%w/w) |
|
| In a water soluble Ointment base |
q.s |
| |
|
|
| 12. |
Clotrimazole IP. |
1% w/w |
| Gentamicin Sulphate IP |
|
| Equivalent to Gentamicin |
0.1%w/w |
| In a cream base |
q.s |
| |
|
|
| 13. |
Clotrimazole IP |
1.0% w/w |
| Beclomethasone Dipropionate IP |
0.025% w/w |
| Neomycin Sulphate IP |
0.5% w/w |
| In a cream base |
q.s |
| |
|
|
| 14. |
Each gram contains |
|
| Betamethasone Dipropionate USP |
0.643mg |
| Gentamicin Sulphate IP |
|
| Equivalent to Gentamicin base |
1mg |
| Tolnaftate USPTolnaftate USP |
10 mg10 mg |
| Iodochlorhydroxyquinoline IP |
10 mg |
| Chlorocresol IP (Preservative): |
1 mg |
| In cream base q.s.to make |
1 g |
| |
|
|
| 15. |
Clobetasol Propionate USP |
0.05%w/w |
| Zinc Sulphate IP. |
2.5%w/w |
| Gentamicin Sulphate IP |
|
| Equivalent to Gentamicin |
0.1%w/w |
| In a cream base |
q.s |
| |
|
|
| 16. |
Clobetasol Propionate BP |
0.05%w/w |
| Neomycin Sulphate IP |
0.5%w/w |
| In a cream base |
q.s |
| |
|
|
| 17. |
Clobetasol Propionate BP |
0.05%w/w |
| Micoazole Nitrate IP |
2.0%w/w |
| Neomycin Sulphate IP |
0.5%w/w |
| In a cream base |
q.s |
| |
|
|
| 18. |
Sodium Pyrrolidone Carboxylic Acid Solution |
|
| Equivalent to Sodium Pyrrolidone |
|
| Carboxylic Acid |
2.5%w/w |
| Sodium Lactate Solution USP |
|
| Equivalent to Sodium Lactate |
2.5%w/w |
| Olive Oil BP |
3.0%w/w |
| Vitamin E Acetate IP |
1.0%w/w |
| In Perfume cream base |
q.s |
| |
|
|
| 19. |
Mupirocin BP |
2.0% w/w |
| In a water soluble base |
q.s |
| |
|
|
| 20. |
Clobetasol Propionate BP |
0.05%w/w |
| Micoazole Nitrate IP |
2.0%w/w |
| Gentamicin Sulphate IP |
|
| Equivalent to Gentamicin |
0.1%w/w |
| In a cream base |
q.s |
| |
|
|
| 21. |
Betamethasone Dipropionate USP |
|
| Equivalent to Betamethasone |
0.05%w/w |
| In a cream base |
q.s |
| |
|
|
| 22. |
Mometasone Furoate USPMometasone Furoate USP |
1 mg.1 mg. |
| In a cream base |
q.s |
| |
|
|
| 23. |
Fluconazole gel USP |
0.5% w/w |
| In an aqueous gel base. |
q.s |
| |
|
|
| 24. |
Adapalene |
0.1% w/w |
| In an aqueous gel base. |
q.s |
| |
|
|
| 25. |
Each g contains : |
|
| Fusidic Acid IP |
20 mg |
| Potassium Sorbate BP (as preservative) |
2.7 mg |
| In a cream base |
q.s |
| |
|
|
| 26. |
Each g contains : |
|
| Sodium Fusidate IP |
20 mg |
| In a neutral ointment base |
q.s |
| |
|
|
| 27. |
Each g contains : |
|
| Mucopolysaccharide Polysulfate |
|
| Corresponding to 250 U in a cream base |
|
| In a cream base |
q.s |
| |
|
|
| 28. |
Diclofenac Diethyl ammonium |
|
| Equivalent to Diclofenac Sodium IP |
1% w/w |
| Gel Base |
q.s |
| |
|
|
| 29. |
Diclofenac Diethyl ammonium |
1.16%w/w |
| Equivalent to Diclofenac Sodium IP |
1%w/w |
| Linseed Oil IP. |
3%w/w |
| Methyl Salicylate IP |
20%w/w |
| Menthol IP |
10%w/w |
| Ointment base |
q.s |
| |
|
|
| 30. |
Clotrimazole IP |
1%w/w |
| Beclomethasone Dipropionate IP |
0.025% w/w |
| Gentamicin Sulphate IP |
|
| Equivalent to Gentamicin |
0.1%w/w |
| In cream base |
q.s |
| |
|
|
| 31. |
Hydrous Benzoyl Peroxide BP |
|
| Equivalent to Anhydrous Benzoyl peroxide |
2.5% w/w |
| In an aqueous gel base q.s. with GlycerolIn an aqueous gel base q.s. with Glycerol |
|
| and Acrylate copolymer |
q.s |
| |
|
|
| 32. |
Hydrous Benzoyl Peroxide BP |
|
| Equivalent to Anhydrous Benzoyl peroxide |
5% w/w |
| In an aqueous gel base q.s. with Glycerol |
|
| and Acrylate copolymer |
q.s |
| |
|
|
| 33. |
Clindamycin Phosphate Gel USP |
|
| Equivalent to Clindamycin |
1.0%w/w |
| in a watersoluble gel base |
q.s |
| |
|
|
| 34. |
Linseed Oil BP |
3.0%w/w |
| Diclofenac Diethylamine BP |
1.16%w/w |
| Methyl Salicylate IP |
10%w/w |
| Menthol IP |
5%w/w |
| Benzyl Alcohol IP (as preservative) |
1.0%w/w |
| Gel base |
q.s |
| |
|
|
| 35. |
Nifedipine IP |
0.30% |
| Lidocaine BP |
1.50% |
| In Cream Base |
q.s |